Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
The Journal of Knee Surgery|February 22, 2021
Lateral Meniscus Height and ACL Reconstruction Failure: A Nested Case-Control StudyIskandar Tamimi, David Bautista Enrique, Motaz Alaqueel, et al.Orthopaedic Journal of Sports Medicine|May 5, 2021
A Quantifiable Risk Factor for ACL Injury: Applied Mathematics to Model the Posterolateral Tibial Plateau Surface GeometryJimmy Tat, Drew Crapser, Motaz Alaqeel, et al.Mutation Research|June 24, 2008
Evaluation of the Litron In Vitro MicroFlow Kit for the flow cytometric enumeration of micronuclei (MN) in mammalian cellsJoanne E Collins, Patricia C Ellis, Angela T White, et al.Pharmacoepidemiology and Drug Safety|December 6, 2018
Comparing external and internal validation methods in correcting outcome misclassification bias in logistic regression: A simulation study and application to the case of postsurgical venous thromboembolism following total hip and knee arthroplastyJiayi Ni, Kaberi Dasgupta, Suzan R Kahn, et al.Mutagenesis|December 19, 2023
Ames test study designs for nitrosamine mutagenicity testing: qualitative and quantitative analysis of key assay parametersDean N Thomas, John W Wills, Helen Tracey, et al.Orthopaedic Journal of Sports Medicine|September 27, 2021
A Prediction Model for Primary Anterior Cruciate Ligament Injury Using Artificial IntelligenceIskandar Tamimi, Joaquin Ballesteros, Almudena Perez Lara, et al.Mutagenesis|January 6, 2024
N-Nitrosodimethylamine investigations in Muta™Mouse define point-of-departure values and demonstrate less-than-additive somatic mutant frequency accumulationsAnthony M Lynch, Jonathan Howe, Deon Hildebrand, et al.Mutagenesis|November 1, 2024
Resolution of historically discordant Ames test negative/rodent carcinogenicity positive N-nitrosamines using a sensitive, OECD-aligned designDean N Thomas, John W Wills, Mark Burman, et al.JAMA Ophthalmology|May 8, 2025
Characterization of Belantamab Mafodotin-Induced Corneal Changes in Patients With Multiple MyelomaVivian Lee, Malin Hultcrantz, Stephanie Petrone, et al.Pageof 3